Literature DB >> 4909632

Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine.

T E Hanlon, K Y Ota, A A Kurland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4909632

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN: 0012-3714


× No keyword cloud information.
  8 in total

1.  Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

Review 2.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

3.  Benzodiazepines in psychotic States.

Authors:  J Ananth; O Solano
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

Review 4.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 5.  Fluphenazine (oral) versus placebo for schizophrenia.

Authors:  Hosam E Matar; Muhammad Qutayba Almerie; Stephanie Sampson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-17

6.  Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?

Authors:  R L Singhal; R B Rastogi; Y D Lapierre
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

7.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

Review 8.  Fluphenazine (oral) versus placebo for schizophrenia.

Authors:  Hosam E Matar; Muhammad Qutayba Almerie; Stephanie J Sampson
Journal:  Cochrane Database Syst Rev       Date:  2018-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.